Negative regulators of integrin activity

dc.contributor.authorPouwels J
dc.contributor.authorNevo J
dc.contributor.authorPellinen T
dc.contributor.authorYlanne J
dc.contributor.authorIvaska J
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=biokemia|en=Biochemistry|
dc.contributor.organization-code1.2.246.10.2458963.20.18586209670
dc.contributor.organization-code1.2.246.10.2458963.20.49728377729
dc.converis.publication-id1605594
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/1605594
dc.date.accessioned2022-10-28T14:43:02Z
dc.date.available2022-10-28T14:43:02Z
dc.description.abstractIntegrins are heterodimeric transmembrane adhesion receptors composed of alpha- and beta-subunits. They are ubiquitously expressed and have key roles in a number of important biological processes, such as development, maintenance of tissue homeostasis and immunological responses. The activity of integrins, which indicates their affinity towards their ligands, is tightly regulated such that signals inside the cell cruicially regulate the switching between active and inactive states. An impaired ability to activate integrins is associated with many human diseases, including bleeding disorders and immune deficiencies, whereas inappropriate integrin activation has been linked to inflammatory disorders and cancer. In recent years, the molecular details of integrin 'inside-out' activation have been actively investigated. Binding of cytoplasmic proteins, such as talins and kindlins, to the cytoplasmic tail of beta-integrins is widely accepted as being the crucial step in integrin activation. By contrast, much less is known with regard to the counteracting mechanism involved in switching integrins into an inactive conformation. In this Commentary, we aim to discuss the known mechanisms of integrin inactivation and the molecules involved.
dc.format.pagerange3271
dc.format.pagerange3280
dc.identifier.jour-issn0021-9533
dc.identifier.olddbid189855
dc.identifier.oldhandle10024/172949
dc.identifier.urihttps://www.utupub.fi/handle/11111/45005
dc.identifier.urnURN:NBN:fi-fe2021042714202
dc.language.isoen
dc.okm.affiliatedauthorPouwels, Jeroen
dc.okm.affiliatedauthorIvaska, Johanna
dc.okm.affiliatedauthorDataimport, Biotekniikan keskuksen yhteiset
dc.okm.discipline1182 Biochemistry, cell and molecular biologyen_GB
dc.okm.discipline318 Medical biotechnologyen_GB
dc.okm.discipline1182 Biokemia, solu- ja molekyylibiologiafi_FI
dc.okm.discipline318 Lääketieteen bioteknologiafi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherCOMPANY OF BIOLOGISTS LTD
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.doi10.1242/jcs.093641
dc.relation.ispartofjournalJournal of Cell Science
dc.relation.issue14
dc.relation.volume125
dc.source.identifierhttps://www.utupub.fi/handle/10024/172949
dc.titleNegative regulators of integrin activity
dc.year.issued2012

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
Pouwels JCS review.pdf
Size:
1.18 MB
Format:
Adobe Portable Document Format